New VitA-Pos Eye Ointment Introduced for night time use

AFT Pharmaceuticals is pleased to announce the launch of the new VitA-POS® eye ointment to the Australian market.

VitA-POS® is a smooth, preservative-free eye ointment containing Vitamin A that prevents evaporation from the ocular surface during the night.

It improves the tear film and provides valuable protection of the ocular surface during sleep for all forms and severity of dry eye. VitA-POS® is both preservative-free and phosphate-free, and contains the equivalent of 250 IU of Vitamin A per gram.

VitA-POS® eye ointment also has a use-up period of six months after opening, and more than 300 applications are possible from a 5g pack.

Find out more about VitA-POS®

November 20, 2025

AFT delivers 10th consecutive first half revenue increase

AFT Pharmaceuticals (NZX: AFT, ASX: AFP) today reports a strong first-half performance for the six months to 30 September 2025, with revenue growing 3…

Read More

November 12, 2025

AFT Pharmaceuticals Brings Next-Generation Liposomal Collagen and Wellness Range to the U.S. Market 

AFT Pharmaceuticals has launched its full Lipo-Sachets® range in the U.S., featuring advanced collagen and vitamin supplements powered by patented LI…

Read More

September 25, 2025

On track for $300m FY27 revenue; positive iron IV study result

– Sales tracking in line with $300 million FY27 revenue target – Clinical trial supports the potential patient benefits of novel iron IV development …

Read More